BioCardia (BCDA) Amortization of Deferred Charges (2019 - 2021)

BioCardia (BCDA) has reported Amortization of Deferred Charges for 3 consecutive years, with $144000.0 the latest figure, recorded in Q3 2021.

• On a quarterly basis, Amortization of Deferred Charges rose 13.39% year-over-year to $144000.0 in Q3 2021; TTM through Sep 2021 was $548000.0, a 13.46% increase from a year earlier, with the FY2020 full-year figure at $498000.0, up 13.18% from the prior year.
• Amortization of Deferred Charges was $144000.0 for Q3 2021 at BioCardia, up from $139000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $144000.0 in Q3 2021 and troughed at $105000.0 in Q1 2019.
• A 3-year average of $123272.7 and a median of $123000.0 in 2020 frame the typical range for Amortization of Deferred Charges.
• Across the five-year window, Amortization of Deferred Charges grew 12.38% in 2020 and rose 14.41% in 2021, its largest moves.
• Over 3 years, Amortization of Deferred Charges stood at $115000.0 in 2019, then advanced by 13.04% to $130000.0 in 2020, then climbed by 10.77% to $144000.0 in 2021.
• The last three Amortization of Deferred Charges figures came in at $144000.0 (Q3 2021), $139000.0 (Q2 2021), and $135000.0 (Q1 2021), per Business Quant data.